Difference between revisions of "User:Shawndouglas/sandbox/sublevel35"

From LIMSWiki
Jump to navigationJump to search
Line 105: Line 105:


* [https://www.australia.gov.au/ Australian Government]
* [https://www.australia.gov.au/ Australian Government]
* [https://www.ecdc.europa.eu/en/coronavirus European CDC]
* [https://www.ecdc.europa.eu/en/novel-coronavirus/laboratory-support European CDC]
* [https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19.html Government of Canada]
* [https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19.html Government of Canada]
* [https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/newpage_00032.html Government of Japan]
* [https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/newpage_00032.html Government of Japan]

Revision as of 16:23, 9 April 2020

4. Final thoughts and additional resources

4.1 Final thoughts

4.2 Key guidance documents













4.3 Web portals

4.3.1 U.S. agency portals

4.3.2 U.S. state and territory portals

U.S. territories


4.3.3 Other national and multinational portals

World Health Organization (WHO) and regionals

4.4 Key journal articles


  • Iwen, P.C.; Stiles, K.L.; Pantella, M.A. (2020). "Safety considerations in the laboratory testing of specimens suspected or known to contain the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)". American Journal of Clinical Pathology: aqaa047. doi:10.1093/ajcp/aqaa047. PMID 32190890. 


  • Loeffelholz, M.J.; Tang, T.-W. (2020). "Laboratory diagnosis of emerging human coronavirus infections – The state of the art". Emerging Microbes & Infections 9 (1): 747–56. doi:10.1080/22221751.2020.1745095. PMID 32196430. 


4.5 Public health lab directory

4.6 National and global resources

4.7 Public health laboratory informatics solutions